サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：在宅薬物乱用（DOA）検査市場規模-タイプ別、サンプルタイプ別、世界予測2023年～2032年
市場調査レポート
商品コード
1361116

在宅薬物乱用（DOA）検査市場規模-タイプ別、サンプルタイプ別、世界予測2023年～2032年

At-home Drug of Abuse (DOA) Testing Market Size - By Type (Test Cups, Test Strips), By Sample Type (Saliva, Urine, Blood) & Global Forecast 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 210 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
在宅薬物乱用（DOA）検査市場規模-タイプ別、サンプルタイプ別、世界予測2023年～2032年
出版日: 2023年08月18日
発行: Global Market Insights Inc.
ページ情報: 英文 210 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家庭用薬物乱用（DOA）検査市場規模は、2023年から2032年にかけてCAGR 7％を記録すると予測されます。

これは、薬物スクリーニングが公共の安全を維持し、健全な労働力を確保する上で果たす重要な役割に対する認識と認識が高まっているためです。例えば、マサチューセッツ州では、キシラジンのテストストリップを配布する多くの有害物質削減プログラムを開始しました。キシラジンは皮膚に傷を作り、過剰摂取の場合には死に至る可能性があるため、薬物検査は大きな役割を果たします。

薬物乱用の増加に伴い、雇用主は従業員に対して薬物検査方針を採用するようになってきています。このような意識の高まりにより、家庭用薬物検査キットの需要が高まっています。

在宅薬物乱用検査市場全体は、タイプ、サンプルタイプ、地域によって区分されます。

テストカップは、薬物スクリーニングのためのユーザーフレンドリーなオールインワン・ソリューションを提供し、プロセスをより簡単にし、ミスを少なくするため、2023年から2032年にかけてCAGRが約7.3%になると予測されています。同時にメーカー各社は、一体型温度ストリップ、不純物チェック、複数の薬物を同時に検査できる機能など、常に新しい機能を導入しています。検査カップは、家庭で簡単に実施できる費用対効果の高い効率的な薬物検査ソリューションへの要望を反映しています。

血液サンプル分野は、非侵襲的で苦痛のない検査方法への嗜好の高まりにより、2023年から2032年にかけてCAGR 7.3％を記録すると予想されます。従来の尿ベースの検査は、特に在宅環境では、時に不快で侵襲的な場合があります。血液サンプル検査は、侵襲性が低く、より控えめで、正確な結果を提供できる代替手段を提供します。技術が進歩し続けるにつれて、血液サンプル検査はさらに使いやすく、利用しやすくなり、この分野の成長に有利になると予想されます。

アジア太平洋地域の在宅薬物乱用検査市場規模は、特に職場や教育機関における健康と安全の重視の高まりによって、2032年までのCAGRが8.2%になると予測されます。同地域の政府や組織は、薬物乱用問題と闘うために定期的な薬物スクリーニングの必要性を認識しています。急速な都市化と可処分所得の増加は、家庭用薬物検査キットをより多くの人々にとってより身近なものとし、APAC市場のダイナミクスにプラスの影響を与えるであろう。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 家庭用乱用薬物（DOA）検査業界考察

  • COVID-19インパクト分析
  • 業界エコシステム分析
  • 技術情勢
  • 規制状況
  • 業界への影響要因
    • 促進要因
      • 違法薬物の生産量の増加
      • 薬物乱用抑制に向けた政府の取り組みの高まり
      • 医薬品へのアクセス急増
      • 技術の進歩と製品ポートフォリオの拡大
    • 業界の潜在的リスク＆課題
      • 少量の特殊薬物を検出できない検査製品
      • 薬物検査に対する認識不足
  • 成長可能性分析
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 主要市場プレーヤーの競合分析
    • Abbott Laboratories
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche AG
  • 競合のポジショニング・マトリックス
  • 戦略展望マトリックス

第5章 在宅薬物乱用（DOA）検査市場推定・予測：タイプ別

  • 主要動向：タイプ別
  • テストカップ
  • テストストリップ
  • その他

第6章 在宅薬物乱用（DOA）検査市場の推定・予測：サンプルタイプ別

  • 主要動向：サンプルタイプ別
  • 唾液
  • 尿
  • 血液
  • その他

第7章 家庭用乱用薬物（DOA）検査市場の推定・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • スイス
    • オランダ
    • デンマーク
    • ポーランド
    • スウェーデン
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • ニュージーランド
    • タイ
    • ベトナム
    • インドネシア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • トルコ

第8章 企業プロファイル

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • Assure Tech.（Hangzhou）Co., LTD
  • Atlas Medical GmbH
  • Confirm BioSciences
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Psychemedics Corporation
  • OraSure Technologies, Inc.
図表

Data Tables

  • TABLE 1. Industry impact forces
  • TABLE 2. Competitive analysis of major market players
  • TABLE 3. Competitive positioning matrix: Classification criteria
  • TABLE 4. Test cups market size, 2018 - 2024 (USD Million)
  • TABLE 5. Test cups market size, 2025 - 2032 (USD Million)
  • TABLE 6. Test cups market volume, 2018 - 2024 (Units)
  • TABLE 7. Test cups market volume, 2025 - 2032 (Units)
  • TABLE 8. Test strips market size, 2018 - 2024 (USD Million)
  • TABLE 9. Test strips market size, 2025 - 2032 (USD Million)
  • TABLE 10. Test strips market volume, 2018 - 2024 (Units)
  • TABLE 11. Test strips market volume, 2025 - 2032 (Units)
  • TABLE 12. Others market size, 2018 - 2024 (USD Million)
  • TABLE 13. Others market size, 2025 - 2032 (USD Million)
  • TABLE 14. Others market volume, 2018 - 2024 (Units)
  • TABLE 15. Others market volume, 2025 - 2032 (Units)
  • TABLE 16. Saliva market size, 2018 - 2024 (USD Million)
  • TABLE 17. Saliva market size, 2025 - 2032 (USD Million)
  • TABLE 18. Urine market size, 2018 - 2024 (USD Million)
  • TABLE 19. Urine market size, 2025 - 2032 (USD Million)
  • TABLE 20. Blood market size, 2018 - 2024 (USD Million)
  • TABLE 21. Blood market size, 2025 - 2032 (USD Million)
  • TABLE 22. Others market size, 2018 - 2024 (USD Million)
  • TABLE 23. Others market size, 2025 - 2032 (USD Million)
  • TABLE 24. North America at-home drug of abuse (DOA) testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 25. North America at-home drug of abuse (DOA) testing market size, by country, 2025 - 2032 (USD Million)
  • TABLE 26. North America at-home drug of abuse (DOA) testing market volume, by country, 2018 - 2024 (Units)
  • TABLE 27. North America at-home drug of abuse (DOA) testing market volume, by country, 2025 - 2032 (Units)
  • TABLE 28. North America at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 29. North America at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 30. North America at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 31. North America at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 32. North America at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 33. North America at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 34. U.S. at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 35. U.S. at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 36. U.S. at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 37. U.S. at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 38. U.S. at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 39. U.S. at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 40. Canada at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 41. Canada at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 42. Canada at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 43. Canada at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 44. Canada at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 45. Canada at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 46. Europe at-home drug of abuse (DOA) testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 47. Europe at-home drug of abuse (DOA) testing market size, by country, 2025 - 2032 (USD Million)
  • TABLE 48. Europe at-home drug of abuse (DOA) testing market volume, by country, 2018 - 2024 (Units)
  • TABLE 49. Europe at-home drug of abuse (DOA) testing market volume, by country, 2025 - 2032 (Units)
  • TABLE 50. Europe at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 51. Europe at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 52. Europe at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 53. Europe at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 54. Europe at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 55. Europe at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 56. Germany at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 57. Germany at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 58. Germany at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 59. Germany at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 60. Germany at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 61. Germany at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 62. UK at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 63. UK at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 64. UK at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 65. UK at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 66. UK at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 67. UK at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 68. France at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 69. France at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 70. France at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 71. France at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 72. France at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 73. France at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 74. Italy at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 75. Italy at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 76. Italy at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 77. Italy at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 78. Italy at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 79. Italy at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 80. Spain at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 81. Spain at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 82. Spain at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 83. Spain at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 84. Spain at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 85. Spain at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 86. Switzerland at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 87. Switzerland at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 88. Switzerland at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 89. Switzerland at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 90. Switzerland at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 91. Switzerland at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 92. The Netherlands at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 93. The Netherlands at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 94. The Netherlands at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 95. The Netherlands at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 96. The Netherlands at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 97. The Netherlands at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 98. Poland at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 99. Poland at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 100. Poland at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 101. Poland at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 102. Poland at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 103. Poland at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 104. Denmark at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 105. Denmark at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 106. Denmark at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 107. Denmark at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 108. Denmark at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 109. Denmark at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 110. Sweden at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 111. Sweden at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 112. Sweden at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 113. Sweden at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 114. Sweden at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 115. Sweden at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 116. Asia Pacific at-home drug of abuse (DOA) testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 117. Asia Pacific at-home drug of abuse (DOA) testing market size, by country, 2025 - 2032 (USD Million)
  • TABLE 118. Asia Pacific at-home drug of abuse (DOA) testing market volume, by country, 2018 - 2024 (Units)
  • TABLE 119. Asia Pacific at-home drug of abuse (DOA) testing market volume, by country, 2025 - 2032 (Units)
  • TABLE 120. Asia Pacific at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 121. Asia Pacific at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 122. Asia Pacific at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 123. Asia Pacific at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 124. Asia Pacific at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 125. Asia Pacific at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 126. China at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 127. China at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 128. China at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 129. China at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 130. China at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 131. China at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 132. Japan at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 133. Japan at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 134. Japan at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 135. Japan at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 136. Japan at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 137. Japan at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 138. India at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 139. India at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 140. India at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 141. India at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 142. India at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 143. India at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 144. Australia at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 145. Australia at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 146. Australia at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 147. Australia at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 148. Australia at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 149. Australia at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 150. South Korea at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 151. South Korea at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 152. South Korea at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 153. South Korea at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 154. South Korea at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 155. South Korea at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 156. New Zealand at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 157. New Zealand at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 158. New Zealand at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 159. New Zealand at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 160. New Zealand at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 161. New Zealand at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 162. Thailand at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 163. Thailand at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 164. Thailand at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 165. Thailand at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 166. Thailand at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 167. Thailand at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 168. Vietnam at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 169. Vietnam at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 170. Vietnam at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 171. Vietnam at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 172. Vietnam at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 173. Vietnam at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 174. Indonesia at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 175. Indonesia at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 176. Indonesia at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 177. Indonesia at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 178. Indonesia at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 179. Indonesia at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 180. Latin America at-home drug of abuse (DOA) testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 181. Latin America at-home drug of abuse (DOA) testing market size, by country, 2025 - 2032 (USD Million)
  • TABLE 182. Latin America at-home drug of abuse (DOA) testing market volume, by country, 2018 - 2024 (Units)
  • TABLE 183. Latin America at-home drug of abuse (DOA) testing market volume, by country, 2025 - 2032 (Units)
  • TABLE 184. Latin America at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 185. Latin America at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 186. Latin America at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 187. Latin America at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 188. Latin America at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 189. Latin America at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 190. Brazil at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 191. Brazil at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 192. Brazil at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 193. Brazil at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 194. Brazil at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 195. Brazil at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 196. Mexico at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 197. Mexico at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 198. Mexico at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 199. Mexico at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 200. Mexico at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 201. Mexico at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 202. Argentina at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 203. Argentina at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 204. Argentina at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 205. Argentina at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 206. Argentina at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 207. Argentina at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 208. Colombia at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 209. Colombia at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 210. Colombia at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 211. Colombia at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 212. Colombia at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 213. Colombia at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 214. Chile at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 215. Chile at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 216. Chile at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 217. Chile at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 218. Chile at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 219. Chile at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 220. Middle East & Africa at-home drug of abuse (DOA) testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 221. Middle East & Africa at-home drug of abuse (DOA) testing market size, by country, 2025 - 2032 (USD Million)
  • TABLE 222. Middle East & Africa at-home drug of abuse (DOA) testing market volume, by country, 2018 - 2024 (Units)
  • TABLE 223. Middle East & Africa at-home drug of abuse (DOA) testing market volume, by country, 2025 - 2032 (Units)
  • TABLE 224. Middle East & Africa at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 225. Middle East & Africa at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 226. Middle East & Africa at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 227. Middle East & Africa at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 228. Middle East & Africa at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 229. Middle East & Africa at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 230. South Africa at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 231. South Africa at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 232. South Africa at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 233. South Africa at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 234. South Africa at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 235. South Africa at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 236. Saudi Arabia at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 237. Saudi Arabia at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 238. Saudi Arabia at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 239. Saudi Arabia at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 240. Saudi Arabia at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 241. Saudi Arabia at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 242. UAE at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 243. UAE at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 244. UAE at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 245. UAE at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 246. UAE at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 247. UAE at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)
  • TABLE 248. Turkey at-home drug of abuse (DOA) testing market size, by type, 2018- 2024 (USD Million)
  • TABLE 249. Turkey at-home drug of abuse (DOA) testing market size, by type, 2025- 2032 (USD Million)
  • TABLE 250. Turkey at-home drug of abuse (DOA) testing market volume, by type, 2018- 2024 (Units)
  • TABLE 251. Turkey at-home drug of abuse (DOA) testing market volume, by type, 2025- 2032 (Units)
  • TABLE 252. Turkey at-home drug of abuse (DOA) testing market size, by sample type, 2018 - 2024 (USD Million)
  • TABLE 253. Turkey at-home drug of abuse (DOA) testing market size, by sample type, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Research design
  • FIG. 2 Data collection techniques
  • FIG. 3 Primary research process
  • FIG. 4 Market sizing approach
  • FIG. 5 Forecasting model
  • FIG. 6 Global industry snapshot
  • FIG. 7 Industry ecosystem analysis
  • FIG. 8 Growth potential analysis, by type
  • FIG. 9 Growth potential analysis, by sample type
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company market share analysis, 2022
  • FIG. 13 Competitive analysis of major market players, 2022
  • FIG. 14 Competitive positioning matrix, 2022
  • FIG. 15 Strategic outlook matrix, 2022
目次
Product Code: 6485

At-home drug of abuse (DOA) testing market size is predicted to record 7% CAGR from 2023 to 2032 due to the increasing awareness and recognition of the critical role that drug screening plays in maintaining public safety and ensuring a healthy workforce. For instance, Massachusetts has launched many harm reduction programs through which test strips for xylazine is being distributed. As the drug has the capability of producing gaping skin wounds and can also cause death in case of overdose, drug screening plays a major role.

With rising prevalence of substance abuse, employers are increasingly adopting drug testing policies for employees, while parents and individuals are also using it for specific purposes. This heightened awareness has led to greater demand for at-home drug testing kits.

The overall at-home drug of abuse testing market is divided based on type, sample type, and region.

The test cups segment is predicted to observe around 7.3% CAGR from 2023 to 2032 as they offer a user-friendly, all-in-one solution for drug screening, making the process more straightforward and less prone to errors. Simultaneously, manufacturers are constantly introducing new features, such as integrated temperature strips, adulteration checks, and the ability to test for multiple drugs simultaneously. Test cups reflects the desire for cost-effective and efficient drug testing solutions that can be easily performed at home.

The blood sample segment is expected to record 7.3% CAGR from 2023 to 2032 due to the growing preference for non-invasive and painless testing methods. Traditional urine-based testing can sometimes be uncomfortable and invasive, especially in at-home settings. Blood sample testing provides an alternative that is less invasive, more discreet, and can offer accurate results. As technology continues to advance, blood sample testing is expected to become even more user-friendly and accessible, favoring the segment growth.

Asia Pacific at-home drug of abuse testing market size is anticipated to witness 8.2% CAGR through 2032 driven by an increased emphasis on health and safety, especially in the workplace and educational institutions. Governments and organizations in the region are recognizing the need for regular drug screening to combat substance abuse issues. The rapid urbanization and increased disposable income, which make at-home drug testing kits more accessible to a wider population, will positively sway the APAC market dynamics.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global at-home drug of abuse (DOA) testing market 360 degree synopsis, 2018 - 2032
  • 2.2 Regional trends
  • 2.3 Type trends
  • 2.4 Sample type trends

Chapter 3 At-home Drug of Abuse (DOA) Testing Industry Insights

  • 3.1 COVID- 19 impact analysis
  • 3.2 Industry ecosystem analysis
  • 3.3 Technology landscape
  • 3.4 Regulatory landscape
  • 3.5 Industry impact forces
    • 3.5.1 Growth drivers
      • 3.5.1.1 Rise in the production of illicit drugs
      • 3.5.1.2 Growing government initiatives to curb drug abuse
      • 3.5.1.3 Surge in access to drugs
      • 3.5.1.4 Technological advancements and product portfolio expansion
    • 3.5.2 Industry pitfalls & challenges
      • 3.5.2.1 Inability of testing products to detect small amounts of special drugs
      • 3.5.2.2 Lack of awareness regarding drug testing
  • 3.6 Growth potential analysis
    • 3.6.1 By type
    • 3.6.2 By sample type
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Competitive analysis of major market players, 2022
    • 4.2.1 Abbott Laboratories
    • 4.2.2 Dragerwerk AG & Co. KGaA
    • 4.2.3 F. Hoffmann-La Roche AG
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic outlook matrix, 2022

Chapter 5 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Type (Revenue and Volume)

  • 5.1 Key trends, by type
  • 5.2 Test cups
  • 5.3 Test strips
  • 5.4 Others

Chapter 6 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Sample Type (Revenue)

  • 6.1 Key trends, by sample type
  • 6.2 Saliva
  • 6.3 Urine
  • 6.4 Blood
  • 6.5 Others

Chapter 7 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Region (Revenue and Volume)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Switzerland
    • 7.3.7 The Netherlands
    • 7.3.8 Denmark
    • 7.3.9 Poland
    • 7.3.10 Sweden
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 New Zealand
    • 7.4.7 Thailand
    • 7.4.8 Vietnam
    • 7.4.9 Indonesia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Colombia
    • 7.5.5 Chile
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Turkey

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 Dragerwerk AG & Co. KGaA
  • 8.3 Assure Tech.(Hangzhou) Co., LTD
  • 8.4 Atlas Medical GmbH
  • 8.5 Confirm BioSciences
  • 8.6 F. Hoffmann-La Roche AG
  • 8.7 Siemens Healthineers AG
  • 8.8 Thermo Fisher Scientific, Inc.
  • 8.9 Bio-Rad Laboratories, Inc.
  • 8.10 bioMérieux SA
  • 8.11 Psychemedics Corporation
  • 8.12 OraSure Technologies, Inc.